European Journal of Clinical Pharmacology

, Volume 37, Issue 6, pp 541–544 | Cite as

Vitamin E and cardiovascular disease

  • J. Kleijnen
  • P. Knipschild
  • G. ter Riet
Special Article

Summary

Randomized clinical trials of the effects of Vitamin E on complaints of intermittent claudication and angina pectoris are reviewed, and their methodological shortcomings are considered. Mechanisms by which Vitamin E might act in cardiovascular disease are discussed. The evidence about the possible pharmacological actions of Vitamin E supports the need for randomized clinical trials. It is concluded that Vitamin E may have a positive effect, especially in intermittent claudication.

Key words

Vitamin E angina pectoris intermittent claudication 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ferrari R, Visioli O, Guarnieri C, Caldarera M (1983) Vitamin E and the heart: Possible role as antioxidant. Acta Vitaminol Enzymol 5: 11–22Google Scholar
  2. 2.
    Mächlin LJ (1984) Vitamin E. In: Mächlin LJ (ed) Handbook of vitamins. Marcel Dekker, New York, pp 99–145Google Scholar
  3. 3.
    Leonard PJ, Losowsk MS (1971) Effect of alpha-tocopherol administration on red cell survival in vitamin E-deficient human subjects. Am J Clin Nutr 24: 388–393Google Scholar
  4. 4.
    Farrell PM, Bieri JG, Fratantoni JF, Wood RE, di Sant' Agnese PA (1977) The occurrence and effects of human vitamin E deficiency. J Clin Invest 60: 233–241Google Scholar
  5. 5.
    Steiner M, Mower R (1982) Mechanism of action of vitamin E on platelet function. Ann NY Acad Sci 393: 289–299Google Scholar
  6. 6.
    Hermann WJ, Ward K, Faucett J (1979) The effect of tocopherol on high-density lipoprotein cholesterol. Am J Clin Pathol 72: 848–852Google Scholar
  7. 7.
    Howard DR, Rundell CA, Batsakis JG (1982) Vitamin E does not modify HDL-cholesterol. Am J Clin Pathol 77: 86–89Google Scholar
  8. 8.
    Stampfer MJ, Willett W, Castelli WP, Taylor JO, Fine J, Hennekens CH (1983) Effect of vitamin E on lipids. Am J Clin Pathol 79: 714–716Google Scholar
  9. 9.
    Cloarec MJ, Perdriset GM, Lamberdiere FA, Colas-Belcour JF, Sanzieres JP, Neufeld HN, Goldbourt U (1987) α-Tocopherol: effect on plasma lipoproteins in hypercholesterolemic patients. Isr J Med Sci 23: 869–872Google Scholar
  10. 10.
    Haeger K (1982) Long-term study of α-tocopherol in intermittent claudication. Ann NY Acad Sci 393: 369–375Google Scholar
  11. 11.
    Shephard RJ (1983) Vitamin E and athletic performance. J Sports Med 23: 461–470Google Scholar
  12. 12.
    Simon-Schnass I, Pabst H (1988) Influence of vitamin E on physical performance. Int J Vit Nutr Res 58: 49–54Google Scholar
  13. 13.
    Stringer MD, Görög PG, Freeman A, Kakkar VV (1989) Lipid peroxides and atherosclerosis. Br Med J 298: 281–284Google Scholar
  14. 14.
    Recommended Dietary Allowances (1980) National Academy of Sciences, Washington, DC, p 64Google Scholar
  15. 15.
    Makinson DH, Oleesky S, Stone RV (1948) Vitamin E in angina pectoris. Lancet 1: 102Google Scholar
  16. 16.
    Donegan CK, Messer AL, Orgain ES, Ruffin JM (1949) Negative results of tocopherol therapy in cardiovascular disease. Am J Med Sci 217: 294–299Google Scholar
  17. 17.
    Travell J, Rinzler SH, Bakst H, Benjamin ZH, Bobb AL (1949) Comparison of effects of alpha-tocopherol and a matching placebo on chest pain in patients with heart disease. Ann NY Acad Sci 52: 345–353Google Scholar
  18. 18.
    Rinzler SH, Bakst H, Benjamin ZH, Bobb AL, Travell J (1950) Failure of alpha tocopherol to influence chest pain in patients with heart disease. Circulation 1: 288–293Google Scholar
  19. 19.
    Anderson TW (1974) Vitamin E in angina pectoris. Can Med Assoc J 110: 401–406Google Scholar
  20. 20.
    Anderson TW, Reid W (1974) A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr 27: 1174–1178Google Scholar
  21. 21.
    Gillilan RE, Mondell B, Warbasse JR (1977) Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 93: 444–449Google Scholar
  22. 22.
    Toone WM (1973) Effects of vitamin E: Good and bad. N Engl J Med 289: 979–980Google Scholar
  23. 23.
    Hamilton M, Wilson GM, Armitage P, Boyd JT (1953) The treatment of intermittent claudication with vitamin E. Lancet 1: 367–370Google Scholar
  24. 24.
    Livingstone PD, Jones C (1958) Treatment of intermittent claudication with vitamin E. Lancet 2: 602–604Google Scholar
  25. 25.
    Williams HTG, Clein LJ, Macbeth RA (1962) Alpha-tocopherol in the treatment of intermittent claudication. A preliminary report. Can Med Assoc J 87: 538–541Google Scholar
  26. 26.
    Clein LJ, Williams HTG, Macbeth RA (1962) The use of alpha-tocopherol in the treatment of intermittent claudication. Can Med Assoc J 86: 215–216Google Scholar
  27. 27.
    Boyd AM, Marks J (1963) Treatment of intermittent claudication. A reappraisal of the value of α-tocopherol. Angiology 14: 198–208Google Scholar
  28. 28.
    Westheim AS, Brox D, Selvaag AW (1975) D-α-tokoferol ved claudicatio intermittens. En klinisk undersokelse. Tidsskr Nor Laegeforen 95: 13–15Google Scholar
  29. 29.
    Ratcliffe AH (1949) Vitamin E in intermittent claudication. Lancet 2: 1128–1131Google Scholar
  30. 30.
    Haeger K (1968) The treatment of peripheral occlusive arterial disease with a α-tocopherol as compared with vasodilatator agents and antiprothrombin (dicumarol). Vasc Dis 5: 199–213Google Scholar
  31. 31.
    Haeger K (1974) Long-time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 27: 1179–81Google Scholar
  32. 32.
    Marks J (1962) Critical appraisal of the therapeutic value of α-tocopherol. Vitam Horm 20: 573–598Google Scholar
  33. 33.
    Boyd AM (1951) Proc Roy Soc Med 44: 985–989Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • J. Kleijnen
    • 1
  • P. Knipschild
    • 1
  • G. ter Riet
    • 1
  1. 1.Department of Epidemiology/Health Care ResearchUniversity of LimburgMaastrichtThe Netherlands

Personalised recommendations